
Francesco Massari: Our First Translational Research from ARON-1α
Francesco Massari, Medical Oncologist focused on Genitourinary Cancer at The University Hospital of Bologna IRCCS, shared a post on X about recent paper he and colleagues co-authored published in Biochemistry and Biophysics Reports.
“Out our first translational research from ARON-1α
mRNA expression, tumor heterogeneity, and response to therapy in patients with advanced renal cell carcinoma treated with immune-based combinations.”
Title: mRNA expression, tumor heterogeneity, and response to therapy in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1α)
Authors: Cristina Aguzzi, Simona De Summa, Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Massimo Nabissi, Mimma Rizzo, Annalisa Zeppellini, Kaisa Sunela, Giulia Sorgentoni, Cinzia Ortega, Francesco Massari, Fernando Sabino Marques Monteiro, Nicola Battelli, Camillo Porta, Giorgio Santoni, Matteo Santoni
Read The Full Article at Biochemistry and Biophysics Reports.
More posts featuring Francesco Massari on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023